Influences of 1-asparaginase on glucose tolerance, serum IRI and insulin activity of the pancreatic extracts were examined.
The animals were divided into 4 groups, a control group, a group treated with cortisone (10 mg/day), a group treated with 1-asparaginase (1, 000 U/kg) and a group treated by combined use of 1-asparaginase and cortisone.
1) In the control group, the average blood glucose levels before, 30, 60, 120, and 180 minutes after oral glucose loading were 84±11, 114±26, 118±22, 108±22, and 90±18 mg/dl, respectively.
In the group treated with cortisone, blood glucose levels were 105±18, 187±25, 178±46, 151±49, and 117±32 mg/dl In the group treated with 1, 000 U/kg of 1-asparaginase, blood glucose levels were 137±83, 232±185, 265±123, 296±136, and 224±123 mg/dl.
In the group treated with a combination of 1-asparaginase with cortisone, blood glucose levels were 255±149, 470±199, 421 ±193, 430±173, and 398±158 mg/dl.
2) Serum IRI levels before, 30, 60, 120, and 180 minutes after oral glucose loading were 21.2±7.9, 26.9±11.3, 36.8 ± 11.8, 29.9± 9.5, and 21.3 ± 8.7 μU/ml in the control group.
In the group treated with cortisone, those were 15.0±2.5, 25.3±7.5, 27.8±12.8, 23.6±4.5, 22.6±10.2 μU/ml, in the group treated with 1-asparaginase, 16.1 ±4.5, 24.3±8.8, 28.63±11.8, 23.7±11.7, 20.8±9.3 μU/ml and in the group treated with a combination of 1-asparaginase with cortisone, 14.1±7.3, 17.2±8.4, 11.0±5.4, 5.6±7.3, 3.8±3.3 μU/ml.
3) Insulin activity of the pancreatic extracts was 2.25±0.74 U per rabbit in the control group 2.20±0.70 U in the cortisone treated group, 2.24± 1.77 U in 1-asparaginase treated group.
In the group treated with combination of 1-asparaginase with cortisone, however, the pancreatic insulin activity was not detectable.
4) The insulinogenic indices (ΔIRI/ΔBS) 30 minutes after glucose loading were 0.33±0.17 in the control group, 0.28±0.19 in the group treated with cortisone, 0.23 ±0.13 in the group treated with 1-asparaginase and 0.04±0.03 in the group treated with a combination of 1-asparaginase with cortisone.
From these results, it was ascertained that 1-asparaginase has a diabetogenic action and this effect was potentiated by cortisone.
View full abstract